section name header

Y-Site Injection Compatibility (1:1 Mixture)

Metronidazole

(Mfr: BRN)(Conc: 2.5 mg/mL)

QMark

Blinatumomab

(Mfr: AMG)(Conc: 0.125 mcg/mLb)

Remarks:

Persistent particulate formation when blinatumomab is added to metronidazole; not observed when order of mixing was reversed

Ref:

3405,3417